Biotech has been misunderstood as inherently risky for years. But that is no longer the case, says Ailsa Craig, fund manager of Schroders’ International Biotechnology Trust.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
